Letters16 November 2010
    Author, Article and Disclosure Information

    Background: Muscle toxicity is the most important adverse effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). The incidence of statin-induced myopathy is debated, depending in part on whether the milder and more common symptoms of muscle ache, weakness, and cramping are part of a continuum that also includes rhabdomyolysis, renal failure, and death. Although creatine kinase (CK) elevation is a marker of injury often used clinically to follow the severity of statin-induced myopathy, it has limited usefulness for defining statin-induced myopathy. For example, muscle-toxicity symptoms and biopsy evidence of mitochondrial dysfunction without CK elevation have been documented during statin therapy ...

    References

    • 1. Phillips PS Haas RH Bannykh S Hathaway S Gray NL Kimura BJ et alScripps Mercy Clinical Research CenterStatin-associated myopathy with normal creatine kinase levels. Ann Intern Med2002;137:581-5. [PMID: 12353945] LinkGoogle Scholar
    • 2. Askari A Vignos PJ Jr Moskowitz RW Steroid myopathy in connective tissue disease. Am J Med1976;61:485-92. [PMID: 973643] CrossrefMedlineGoogle Scholar
    • 3. Meyer RA A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol1988;254:C548-53. [PMID: 3354652] CrossrefMedlineGoogle Scholar
    • 4. De Pinieux G Chariot P Ammi-Saïd M Louarn F Lejonc JL Astier A et alLipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol1996;42:333-7. [PMID: 8877024] CrossrefMedlineGoogle Scholar
    • 5. Tran TT Dai W Sarkar HK Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J Biol Chem2000;275:35708-14. [PMID: 10964923] CrossrefMedlineGoogle Scholar